Real-time enrollment status for this respiratory syncytial virus infections+metapneumovirus clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 1:21 PM UTC
| NCT Number | NCT07628049 |
| Recruiting Status | Recruiting |
| Condition | Respiratory Syncytial Virus Infections+Metapneumovirus |
| Phase | Clinical Trial |
| Target Enrollment | 1,808 participants |
| Active Locations | 2 sites in the US |
| Sponsor | GlaxoSmithKline |
| Last Updated on CT.gov | July 8, 2026 (5 days ago) |
As of July 13, 2026: Clinical trial NCT07628049 is currently recruiting participants. This clinical trial study for respiratory syncytial virus infections+metapneumovirus is actively seeking new participants at 2 locations across the United States. The study is sponsored by GlaxoSmithKline. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07628049 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 2 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07628049 was last updated 5 days ago (July 8, 2026). HelloStudys verifies this status automatically.